BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11776807)

  • 21. [Inhibitive effect of bcl-2 antisense oligodeoxynucleotide on Bcl-2 protein synthesis and cell proliferation in human laryngocarcinoma Hep-2 cells].
    Jing H; Huang W; Qiu J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Feb; 33(1):17-20. PubMed ID: 11498881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells.
    Konturek PC; Kania J; Kukharsky V; Ocker S; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2003 Mar; 54(1):17-32. PubMed ID: 12674216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and reversion of drug resistance- and apoptosis-related genes of a DDP-resistant lung adenocarcinoma cell line A549DDP].
    Wang J; Liu X; Wu M
    Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):422-6. PubMed ID: 11776616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mesangial cell proliferation by antisense oligodeoxynucleotide targeting preproendothelin-1 mRNA in vitro.
    Li M; Chen Y; Zhang Z; Gao J
    Chin Med J (Engl); 1999 Sep; 112(9):790-3. PubMed ID: 11717946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].
    Shen WJ; Dai DQ; Teng Y; Liu J
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
    Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X; Zhang J; Wang L; Wei H; Tian Z
    BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of IGF1 receptor gene antisense oligodeoxynucleotide on T24 urinary bladder cancer cells].
    Sun H; Fan J; Tang X
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):276-8. PubMed ID: 11778548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
    Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
    Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
    Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
    Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
    He DM; Zhang H
    Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
    Morelli S; Alama A; Quattrone A; Gong L; Copreni E; Canti G; Nicolin A
    Anticancer Drug Des; 1996 Jan; 11(1):1-14. PubMed ID: 8639245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y; Cherton-Horvat G; Dragowska V; Baird S; Korneluk RG; Durkin JP; Mayer LD; LaCasse EC
    Clin Cancer Res; 2003 Jul; 9(7):2826-36. PubMed ID: 12855663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibition of angiogenesis in pancreatic carcinoma by cyclooxygenase-2 antisense oligodeoxynucleotides].
    Wang XP; Xie CG; Dong YW; Zhang RL; Wu LY; Wu K
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1501-4. PubMed ID: 14521730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemosensitization of breast carcinoma cells with the use of bcl-2 antisense oligodeoxynucleotide.
    Yang JH; Feng F; Qian H; Cheng H
    Breast; 2004 Jun; 13(3):227-31. PubMed ID: 15177426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bcl-2 antisense oligodeoxyribonucleotide increases apoptosis of lung carcinoma cells induced by cisplatin].
    Ouyang N; Ran P; Qiu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Dec; 23(12):722-4. PubMed ID: 11778475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.